BioNTech reviews

Non transparent plans on transformation, no defined processes

- The salaries are relatively low for a company of its size. - Power politics are very prevalent, where colleagues who accomplish a lot are not acknowledged, while those who communicate with their line managers in a more obedient way regardless of their performance are rewarded. - Promotions and learning opportunities are not distributed fairly. - Acknowledgement of contributions to patents are often lacking due to managers seeking a bigger share. - Intransparency and deliberate misinformation on the levels of upper and middle management. - No proper bonuses. Stock bonuses are kind of a scam and conditions are not communicated properly. - Instead of rehiring colleagues whose positions became redundant in active positions and training them accordingly like how big pharma in Germany typically do, it was resorted to dismissals and lay-offs. - Continued promotions and hirings for favored select few while many colleagues simultaneously face lay-offs. - Very weak and inexperienced workers council. - Management and HR avoid answering questions.